人类健康新闻

阅读针对膳食补充剂和婴儿配方产品的益生菌领域的最新消息。

想要了解更多信息？

Chr. Hansen acquires UAS Laboratories LLC to extend the microbial platform and strengthen probiotic production flexibility

Chr. Hansen acquires HSO Health Care to grow probiotics offering for women’s health

ESPGHAN recommends Chr. Hansen’s probiotics for use in preterm infants

Probiotics may provide relief for infants with colic, new study reveals

全球多达四分之一的婴儿有过度哭闹和烦躁的问题——通常称为腹绞痛。一项新的研究表明，BB-12® 益生菌株可能有助于减少哭闹持续时间和哭闹次数，减轻婴儿及其父母的痛苦

Probiotics may help preterm infants

科汉森新推出的一种三菌株混合产品有助于早产儿肠道的健康和发育，并被证实能够将发生坏死性小肠结肠炎的风险降低 50%

As the dreaded flu-season knocks on our door, a new study reveals a secret weapon to reduce the cost of flu-like sickness

一项新的保健经济研究表明，摄入益生菌有助于降低流感类疾病的治疗成本。研究显示，如果服用益生菌，每年仅在美国就能减少超过 5,400 万天的病假。

Chr. Hansen in joint venture to accelerate momentum in microbiome

科汉森联合推进益生菌开发。丹麦生物科技公司科汉森联合 Lonza AG 向新兴市场推出活性生物治疗产品

World’s best documented probiotic now available for fermented plant bases

科汉森推出 nu-trish® LGG® DA 以进一步提升发酵植物的健康品味

Chr. Hansen reaches major milestone in innovation pipeline

临床试验表明，对于常规使用的家用止痛药造成的内脏损伤，益生菌能够加强防御

文章 | May 13, 2019

精选新型益生菌菌株临床试验的成果发布是科汉森的首创以及朝着新型膳食补充剂商业化的重要一步

New partnership to develop treatment for peanut allergies

食物过敏口服免疫药物开发商Prota Therapeutics公司已与科汉森达成合作。在合作期间，双方将在III期临床试验中对全球文献记录最完备的益生菌菌株LGG®进行评估，以开发花生过敏疗法。

新闻 | 2018 年 4 月 9 日

Andrew Scorey 拥有 25 年的消费者保健行业经验，他将加入科汉森并担任人类健康业务的高级副总裁。

文章 | February 19, 2018

致力于展示世界有记录的最佳益生菌菌株-鼠李糖乳杆菌（LGG®）新网站向您解释 LGG® 菌株为什么是膳食补充剂，婴儿配方奶粉和发酵乳制品的最佳选择的科学建议。

Microbiome is our next generation of probiotics

New and exciting opportunities are emerging in this breakthrough area

文章 | July 5, 2017

将开创性的科学技术转化为新的微生物解决方案，改善保健，预防或治疗疾病

Lactobacillus rhamnosus (LGG®) - the world's best documented probiotic strain

An introduction to the world's best documented probiotic strain.

文章 | March 31, 2017

你知道有些益生菌可能有益于女性泌尿生殖系统的健康吗？

文章 | March 17, 2017

本研究调查了鼠李糖乳杆菌(GR-1)和罗伊氏乳杆菌(RC-14®)对携带有B组链球菌(GBS)群落的孕妇的影响。

To further strengthen its probiotics offering Chr. Hansen acquires LGG®, the world’s best documented probiotic strain, from Valio OY

对于促进人类健康的天然解决方案的需求极大，行业内的微生物解决方案的预期增长率为 7-9%。科汉森是全球领先的用于膳食补充剂、婴儿配方食品和乳制品的益生菌供应商。现在，通过收购 LGG®...

文章 | June 17, 2016

在2016年6月21-23日在匈牙利布达佩斯举办的IPC（国际益生菌和益生元科学研讨会）上，人类健康发现(Human Health Discovery)部门的首席科学家Thomas D....

See how our probiotic drops are made

Our probiotic drops are a convenient solution for infants and young children - safe, easy to dose...

We offer: insight, invention, integrity

我们的 3I 原则描述了我们的工作方式和我们提供的产品/服务。

Our 3 USPs - it works, it lasts, it's different

Add value to your brand with Probio-Tec® probiotics.

Hear Eric Johansen talk about Bifidobacterium (BB-12®)

The BB-12® probiotic strain was introduced to the market in 1985. Today approx. 200 million people...

Chr. Hansen enters first collaboration on production of a next generation probiotic from the Human Microbiome

Today, Chr. Hansen and Caelus Health announce their collaboration on the development of Eubacterium...

One of the world's largest clinical studies on probiotics reinforces significant gastrointestinal benefits of the probiotic strain named BB-12®

Millions of people around the world suffer from a range of gastrointestinal symptoms. Results from...

New study confirms presence of bifidobacteria and lactobacilli in breast milk from Chinese mothers

A study initiated by Chr. Hansen has shown that bifidobacteria and lactobacilli are present in...

Chr. Hansen accelerates efforts within human microbiome

Establishes a new research and development consortium and secures access and commercialization...

新闻 | September 4, 2015

饮料益生菌 - 了解更多有关L. CASEI 431® Juice的信息

新闻 | 2019 年 8 月 26 日

科汉森科学家有关食品生物技术的文章在享有盛誉的科技期刊《Current Opinions in Biotechnology》（生物技术的最新观点）的专刊《Food Biotechnology...